Hiliks Technologies has informed that the Board of Directors at its meeting held on 12th February, 2021 has considered and approved the request received from Alpha Antibiotics, for reclassification of its shareholding from Promoter/ Promoter Group category and removal from the promoter/ promoters list. The approval of the Board towards reclassification is subject to the approval of the members of the Company and the other regulatory authorities, if any, in terms of Regulation 31A of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 and amendments thereof. As required under provisions of Regulation 31A, certified extract of the board meeting minutes is enclosed.
The above information is a part of company’s filings submitted to BSE.
